ID   TR-LCC-1
AC   CVCL_IU63
SY   LCC
DR   CCRID; 1101HUM-PUMC000483
DR   Wikidata; Q54972895
RX   PubMed=28104015;
CC   Population: Chinese.
CC   Doubling time: 201.2 hours (PubMed=28104015).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): CCRID=1101HUM-PUMC000483; PubMed=28104015
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 14,18
ST   D7S820: 8
ST   D8S1179: 14,17
ST   FGA: 25
ST   Penta E: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9CG ! TR-LNN-1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 11
//
RX   PubMed=28104015; DOI=10.3760/cma.j.issn.1673-0860.2017.01.00;
RA   Wang, Ru
RA   Bian, Xiao-Cui
RA   Liu, Yu-Qin
RA   Fang, Ju-Gao
RA   Wang, Hong
RA   Liu, Hong-Gang
RA   Lian, Meng
RA   Ma, Hong-Zhi
RA   Feng, Ling
RA   Wang, Hai-Zhou
RT   "Establishment and characterization of a laryngeal squamous cell
RT   carcinoma cell line.";
RL   Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 52:44-48(2017).
//